|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Trachoma | |||||
| Chlamydia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Chlamydia Infections | |||||
| 3 | More general conditions related to this trial | ||||
| Bacterial Infections | |||||
| Chlamydiaceae Infections | |||||
| Conjunctival Diseases | |||||
| Conjunctivitis | |||||
| Conjunctivitis, Bacterial | |||||
| Corneal Diseases | |||||
| Eye Diseases | |||||
| Eye Infections | |||||
| Eye Infections, Bacterial | |||||
| Genital Diseases, Female | |||||
| Genital Diseases, Male | |||||
| Gram-Negative Bacterial Infections | |||||
| Infection | |||||
| Sexually Transmitted Diseases | |||||
| Sexually Transmitted Diseases, Bacterial | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Azithromycin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| University of California, San Francisco | |||||